CXCL13 and idiopathic pulmonary fibrosis: Cytokines and chemokines, such as CCL18 [35], IL-6 [36], CXCL13 [37], IL-8 (CXCL8) [38], and CTACK, may be directly involved in the pathogenesis of fibrosis and are thus potential targets for IPF treatment.